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Background: The study of the cerebrovascular physiology is crucial to understand the pathogenesis of neurological
disease and the pharmacokinetic of drugs. Appropriate models in vitro often fail to represent in vivo physiology. To
address these issues we propose the use of a novel artificial vascular system that closely mimics capillary and
venous segments of human cerebrovasculature while also allowing for an extensive control of the experimental
variables and their manipulation.
Results: Using hollow fiber technology, we modified an existing dynamic artificial model of the blood–brain barrier
(BBB) (DIV-capillary) to encompass the distal post-capillary (DIV-venules) segments of the brain circulatory system.
This artificial brain vascular system is comprised of a BBB module serially connected to a venule segment. A pump
generates a pulsatile flow with arterial pressure feeding the system. The perfusate of the capillary module achieves
levels of shear stress, pressure, and flow rate comparable to what observed in situ. Endothelial cell exposure to flow
and abluminal astrocytic stimuli allowed for the formation of a highly selective capillary BBB with a trans-endothelial
electrical resistance (TEER; >700 ohm cm2) and sucrose permeability (< 1X10-u cm/sec) comparable to in vivo. The
venule module, which attempted to reproduce features of the hemodynamic microenvironment of venules, was
perfused by media resulting in shear stress and intraluminal pressure levels lower than those found in capillaries.
Because of altered cellular and hemodynamic factors, venule segments present a less stringent vascular bed (TEER
<250 Ohm cm2; Psucrose > 1X10
-4 cm/sec) than that of the BBB. Abluminal human brain vascular smooth muscle
cells were used to reproduce the venular abluminal cell composition.
Conclusion: The unique characteristics afforded by the DIV-BBB in combination with a venule segment will
realistically expand our ability to dissect and study the physiological and functional behavior of distinct segments of
the human cerebrovascular network.
Keywords: Neurological diseases, Shear stress, Venule, Atherosclerosis, Inflammation, Transmural pressure, Cerebral
blood flow, Drug delivery, Organ-on-a-chipBackground
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exciting opportunities for investigative and clinical studies.
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reproduction in any medium, provided the orfor future mechanistic or preclinical studies. A realistic
model of the brain circulation may significantly help
understanding the mechanisms involved in the cerebro-
vascular response to a number of physiological and patho-
logical stimuli. This, in turn will provide new strategies to
accelerate the development on novel central nervous sys-
tem (CNS) drug therapies and reduce the burden of major
neurological disorders. As the research community re-
cognize, mimicking the physiology of multiple vascular
segments in vitro is a challenging task. An ideal cerebro-
vascular model should be able to reproduce the he-
modynamic and cellular characteristics of each vascularl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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capillaries selectively excludes most blood-borne sub-
stances from entering the brain and vice versa [1]. The
venule segment is more permissive and allows leu-
kocyte extravasation [2].
The barrier property of the cerebral vasculature depends
on inter-endothelial tight junctions between adjacent
endothelial cells that limit paracellular diffusion. At the
BBB level, the endothelial cells are also characterized by
low pinocytotic activity, lack of fenestrations, and unique
expression patterns of trans-membrane transport proteins
to regulate traffic into and out of the brain parenchyma
[1]. Therefore, transit across the BBB involves transloca-
tion through the capillary endothelium by asymmetrically
expressed carrier-mediated transport systems. These are
responsible for passage of certain water soluble but bio-
logically important substances such as glucose, mono-
carboxylic acids, amino acids, etc. [1]. Furthermore, in
addition to a physical and a transport barrier the BBB
endothelium acts as a metabolic barrier. This function is
mediated by a BBB-specific cytochrome P450 enzymes that
catalyze the biotransformation of lipids and steroidal hor-
mones, as well as xenobiotics For example, the antiepilep-
tic drug undergoes brain-specific metabolism in addition
to its known conversion by liver P450 enzymes [3].
BBB endothelial cells are surrounded by astrocytic end
feet processes sharing a basal lamina, and enveloping >
99% of the BBB endothelium [4-6]. Astrocyte interactions
with the cerebral endothelium modulate BBB function,
regulate protein expression, facilitate endothelial differen-
tiation and play a major role in the expression and main-
tenance of functional inter-endothelial tight junctions as
well as of other BBB properties [7].Flow plays a crucial role in modulating BBB functions
The exposure to physiological shear stress (SS) also plays
a critical role in modulating BBB functions and facilitat-
ing the differentiation of vascular endothelial cells into a
BBB phenotype [8-10]. Flow across the apical surface of
the vascular endothelium activates a number of mecha-
nosensors (e.g., integrins, caveolae, G proteins, and ion
channels) [11-13] which transduce physical stimuli into
biochemical signals. Despite the variety of potential
mechanosensors present on the luminal side of the
endothelial cell membrane one of the major common
downstream effect is the activation of extracellular-signal-
regulated kinases 1/2 (ER [14] K1/2). These are pleiotropic
modulators of the cell physiology and play an important
role in the control of the expression of gene involved in
the regulation of cell division, apoptosis, cell differenti-
ation and cell migration [9,10,13,15-18]. Interestingly, ex-
pression of these genes in endothelial cells is under the
control of shear stress [10,13].Rheological and architectural characteristics of distal
brain venules
The architecture and cellular milieu of these vessels are
remarkably different from that of the BBB due to the ex-
istence of mural cells (where smooth muscle cells start
gradually appearing in venules with a diameter > 30 μm
up to ≅ 50 μm) [19] and perivascular spaces. This affects
the organization of the inter-endothelial tight junctions
[20], which leads to the formation of a significantly less se-
lective vascular bed than BBB capillaries [21]. There is
general agreement that, venular endothelial cells are
exposed to a significant lower level of SS (between 1.5 to
4.5 dynes/cm2) than those forming the capillary vascular
bed. Direct measurements of shear stress values in BBB
vessels and their venular counterparts are lacking, but
given our previous work showing a direct effect of shear
on the physiological and functional properties of the vas-
cular endothelium it is reasonable to assume that capillary
vs. venules differ in the properties in party owing to shear
levels.
Results
Modular dynamic capillary-venule in vitro system:
Physiology in a box
One of the major limitations of current vascular in vitro
models is their inability to mimic the functional character-
istics and response of multiple vascular segments within
the cerebrovascular network. To address this problem we
have developed a new dynamic in vitro model that recapi-
tulates the hemodynamic, metabolic and functional char-
acteristics of capillary and post-capillary vessels of the
human brain vascular network. The modular assembly of
the system (Figure 1A) originated from a serial combin-
ation of capillary and venule modules. In this configur-
ation, a fully established BBB module influences its
respective venule module through gas permeable silicon
tubing connecting the respective luminal compartments.
Each module reproduces as closely as currently possible
the cellular composition of its corresponding vascular seg-
ment in vivo. In the capillary module, luminal human
primary brain microvascular endothelial cells were co-
cultured with abluminal human astrocytes to mimic the
cellular milieu forming the BBB microcapillaries in vivo.
In the venules module, the abluminal glial cells were
replaced by human vascular smooth muscle (HUSMC) as
observed in distal post-capillary segments of the cerebral
vessels [22]. A peristaltic pump within the system gener-
ated a pre-capillary high flow velocity input characterized
by an arterial systolic-like blood pressure of ≅ 70mmHg
(see Figure 1B). Within the system medium flow moves
through a gas permeable silicon tubing allowing the ex-
change of oxygen and CO2 with the external environment
before entering into the first module (capillary system).
The number of hollow fibers in the capillary (n=3) and
Figure 1 Schematic outline of the DIV capillary-venules model. Note how the system recapitulates both rheological and cellular
characteristics of the corresponding in vivo cerebrovascular segments.
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rheological characteristics (transmural pressure, flow rate
and shear stress) of the corresponding cerebrovascular
segments in vivo [23]. For the experiments shown herein,
the flow rate was between 4.6 and 5.3 mL per minute.
Note the significant pressure reductions observed when
flow passed first through the capillary and then through
venule segments (see Figure 1B). Our data showed that the
transmural pressure and the shear stress were consistent
with the corresponding in vivo observations (see Table 1).
Furthermore, a computer controlled pumping mechanism
allowed us to reproduce a broad range of perfusion sce-Table 1 Side-by-side, comparison between rheological
parameters measured in vitro versus in vivo
Blood Pressure(mmHg) In vivo In vitro
Pre-capillaries 60 70.1 ± 0.2
Capillaries 25 25.5 ± 0.1
Venules 12-15 11.8 ± 0.4
Shear stress(dyne/cm2)
Capillaries 5-23 16.3
Venules 3 ± 1.5 2.6narios, each characterized by different levels of shear
stress, intraluminal pressure, pulsatile rate to reproduce
heart beats/min.
The capillary-venule in vitro system can mimic the
rheological characteristics of the corresponding vascular
segments in vivo
Figure 2A shows changes that occurred in the hemo-
dynamic profile (transmural pressure and shear stress) of
capillary and venule segments in respect to perfusion.
Note that increases in the perfusion rate determined a sig-
nificant proportional increase in both shear stress (dynes/
cm2) and intramural pressure (mmHg) in the capillary
segment (Figure 2A –left panel; red dots). Table 1 shows a
comparison between in vivo and in vitro parameters.
Changes in the corresponding shear stress and intramural
pressure measured in the venule segments are significantly
less evident (Figure 2A –left panel; blue dots). Note (see
Figure 2B) that the tubing connecting the luminal output
of the capillary module to the venules did not affect
the rheological characteristics of flow. This is shown by
comparing post-capillary segment (post CAP) to pre-
venous (Pre VEN) pressure values. Therefore, from a
Figure 2 Rheological characteristics of the DIV capillary-venule system. Panel A: Hemodynamic profile of capillary and venule segments in
respect to perfusion. Panel B: Note that the presence of inter module connector between the capillary and venule lumens did not alter the
rheological profile of flow. The asterisk “*” indicates a statistically significant difference in transmural pressure between capillary and venules
(n=4; p<0.05).
Figure 3 Side by side comparison between in vitro capillary and venule vascular beds. Panel A: Note how the capillary system allows for the
formation of a very stringent vascular bed (high TEER) in comparison to venules (low TEER). (Panel B). Note also that capillary segments established
under venules level of shear stress and venules module exposed to capillary shear stress levels formed a comparable low stringent barrier suggesting
that both abluminal astrocytes and high shear stress levels are necessary to develop a tight vascular bed (Panel C) TEER and sucrose permeability
correlation in capillaries and venules modules. The sigmoid curve symbolize the ideal correlation between TEER and permeability previously
determined by us [55]. Note the difference of ≈ 2 order of magnitude between capillaries (less permeable) and venules (most permeable). The more
stringent vascular bed formed in the capillary module can discriminate drug permeability based on the octanol-water partition coefficient (XlogP) with
a significantly higher degree of selectivity than venules (Panel D). The asterisk “*” indicates a statistically significant difference (n=4; p<0.05).
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Figure 4 Functional characterization of the DIV capillary-venule
system. Hyperosmolar opening of the BBB in DIV models was
assessed by real time measurements of TEER. Similar to what
observed in vivo the differential magnitude and the transient nature
of the vascular opening is indicative of the formation of capillary
and venule vascular beds that closely mimic the physiological
response of the corresponding cerebrovascular segments in situ.
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contiguous vascular system, which however, exhibited dis-
tinct capillary and post-capillary rheological features cha-
racteristics of the corresponding segments in vivo.
Vascular integrity and permeability characteristics of
capillary and venules in vitro
[24] between capillaries and venules in vitro (see
Figure 3C). Furthermore, Figure 3B shows that astrocytes,
in presence of venous perfusion flow, are not sufficient to
induce a high TEER and low paracellular permeability.
However, astrocytes are necessary for the development of
a tight barrier since when venule modules were exposed
to capillary levels of shear stress we did not observe any
significant increase in TEER.
A functional capillary/BBB model must be able to dis-
criminate the permeability to molecules based on their
oil/water partition coefficient. In addition, a capillary-
venule model must be able to differentiate the permeabi-
lity to the same compound between each segment. In fact,
where the tightness of the vascular endothelium is a deter-
mining factor for the permeability the capillary vascular
bed will impede the passage of polar molecule more ef-
fectively than that of the venules. To validate our model
we performed permeability tests across each module using
three different classes of compounds: 1) Sucrose (a well-
established paracellular marker); 2) Phenytoin (an anti-
epileptic drug and a moderate substrate for multidrug
transport systems, e.g., P-glycoprotein); 3) Diazepam (a
benzodiazepine that crosses the BBB by passive diffusion).
Permeability of each compound was calculated for each
segment (capillary and venules) by integrating the area
under the ECS and lumen data points (AUC) between
time 0 and time (t) = 20 minutes (min) according to the
equation described in the methods section [25].
Figure 3D shows the results of the permeability mea-
surements in the capillary and venule segments. Perme-
ability to Diazepam (PDIAZEPAM; logP ≅ 3) measured in the
capillary module was comparable to that observed in the
venules (3.97 × 10-3 ± 1.70 cm/sec and 4.09 × 10-3 ± 2.72
cm/sec respectively). Phenytoin permeability (PPHENYTOIN;
logP ≅ 2.5) measured in the capillary was 2.59 × 10-5 ±
1.22 cm/sec versus 7.20 × 10-5 ± 1.26 cm/sec in the venule.
Sucrose (the least lipophilic compound tested; logP ≅ -3.7)
permeability (PSUCROSE) was 4.39 × 10
-7 ± 2.68cm/sec and
4.93 × 10-5 ± 1.80cm/sec in the capillary and venule seg-
ments respectively.
Vascular response to a hyperosmolar agent
Intracarotid infusion of hyperosmolar [1.6 M] mannitol,
a cell-impermeable and non-toxic polyalcohol, has been
to previously used to reversibly disrupt the BBB in vivo
[26] to facilitate the passage of chemotherapic drugs
(e.g., methotrexate) in the treatment of malignant braintumors [27]. The osmotic opening of the vascular endo-
thelium is a non-energy-dependent mechanism [28] solely
mediated by dehydration of endothelial cells, cerebrovas-
cular dilatation, and contraction of their cytoskeleton pro-
tein structures. We tested the effect of hyperosmolar
mannitol injection on vascular integrity in the capillary
and venule modules. The intravascular compartment of
DIV capillary-venule system was perfused for 120 sec with
hyperosmolar media containing mannitol [1.6 M]. The
flow rate used was 1 mL/min. TEER was measured to as-
sess real-time changes of vascular integrity in the capillary
and venule modules (Figure 4). We observed a transient
(≈ 37 minute ± SEM 4) loss of vascular integrity (TEER
<400 Ohm cm2) in the capillary module. This was paral-
leled by a loss of vascular integrity in the venule module
which was significantly longer in duration (≈ 55 minute ±
SEM 5) although less significant in magnitude.Bioenergetic metabolism of capillary and venule
cerebrovascular segments
The assessment of cell metabolism (glucose consumption/
lactate production) provides important information on
the bioenergetic mechanisms (aerobic-anaerobic) used by
brain vascular segments. Figure 5 shows changes in glu-
cose consumption and lactate production in the vitro ca-
pillary and venule segments. Note that during anaerobic
respiration each molecule of glucose is converted into 2
lactate molecules (glucose consumption/lactate produc-
tion ratio = 2) while during aerobic respiration glucose in
totally converted into CO2 and H2O. In the capillary
Figure 5 Differential bioenergetic behavior of in vitro capillary and venule vascular systems. Panel A: Glucose consumed versus lactate
produced over time in capillary and venule modules. Note the significant difference between the glucose consumption and lactate production
ratio (R) in the capillary module (R≅1) and in the venule (R≅1.5). This indicates that in contrast to venule segments, the brain capillary cellular
elements have increased propensity towards the use of aerobic-based glucose metabolism. The asterisk “*” indicates a statistically significant
difference (n=4; p<0.05) versus parallel systems established under static conditions.
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sumption ratio (1 ± SEM 0.08) was suggestive of a bio-
energetic behavior favoring oxidation. In contrast, in the
venule segment (Figure 5B) we measured a lactate
production-glucose consumption ratio of 1.5 ± SEM 0.14,
thus suggesting that in the presence of reduced vascular
shear stress (in comparison to the capillary segment) the
cellular bioenergetic demand is largely fulfilled through
anaerobic glucose metabolism [10]. These preliminary
results need larger scale validation and experiments where
cell variables (e.g., vascular smooth muscle vs. astrocytes)
are interchanged. This is evident in Figure 5C which
shows the side-by-side comparison of the glucose
consumption-lactate production ratios between capillary
and venule segments established in the DIV system.Discussion
Hemodynamic alterations as well as pro-inflammatory
and exogenous stimuli can adversely affect vascular integ-
rity and lead to the pathogenesis and/or progression of a
number of major neurological disorders [5,29-31]. In vitro
studies are set to support and facilitate our understanding
of the mechanisms involved in the physiological and pa-
thological modulation of cerebrovascular functions. This
is of critical importance for the development of novel
strategies aimed at reducing the burden of CNS disease
associated with brain vascular impairments. Other in vitro
systems have attempted to reproduce the physiological
and functional characteristics of capillary or venular
segments of the cerebrovascular system (e.g., [32,33]).
However, these models lack the ability to reproduce the
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these vascular beds are exposed in vivo.
The use of hollow fiber technology allowed us and
others to establish the first quasi-physiological in vitro
BBB models [34-39] which was then further humanized
[40] to reproduce not only healthy BBB properties but also
properties of multiple drug resistance and leukocyte ex-
travasation [2,24,41]. This technology allows to develop
the first artificial interlinked brain capillaries and venules
segments, which retain their distinct vascular properties.
As shown in Figure 1 the pumping mechanism generates
arterial high velocity flow with a systolic blood pressure
range (80 to 300 mmHg) comparable to in vivo. A dra-
matic drop of perfusion velocity and transmural pressure
occurs when flow enters the capillary segment generating
a vascular shear stress comparable to what has been
reported for non-BBB vessels in vivo [42]. After leaving
the capillary module, the medium flow enters into the
venule module were perivascular astrocytes were replaced
by smooth muscle cells to more closely mimic the in situ
cellular milieu of this vascular segment. At this level sys-
tolic transmural pressure is low (see Figure 2) and flow is
characterized by low shear stress (≅ 3 dynes/cm2; see also
Table 1). It is important to underscore again that direct
measurements of shear levels in brain microvessels is lack-
ing and that the values used in this manuscript are extra-
polations from other vascular beds in vivo [42].
The DIV capillary-venule model not only mimics the
rheological characteristics of the corresponding brain vas-
cular segments but also their functional and physiological
properties (e.g., Table 1). In agreement with previously
published studies BBB capillaries In vivo are characterized
by high TEER, lack of paracellular pathways, low perme-
ability to polar molecules (e.g., paracellular markers) and a
selective permeability that (in the absence of specific ex-
trusion mechanisms) reflects the lipophilicity of the spe-
cific substance [1]. Our results have clearly shown that,
similar to in vivo, the artificial capillary vascular bed was
characterized by a high TEER (see Figure 3A and 3D); low
permeability to the paracellular marker sucrose, and was
capable of selective permeability reproducing the in vivo
rank order of the tested substances (see Figure 3C) [43].
Overall, the relationship between lipophilicity and perme-
ability found in the DIV-capillary module was similar to
that reported by others in vivo [44].
Venules are characterized by a significantly more per-
missive vascular bed with a lower TEER and a reduced
ability to provide a barrier to the passage of polar mole-
cules than capillaries [45]. In this respect, the DIV-venules
showed lower TEER, and a reduced selective permeability
(see Figure 3A, 3C and 3D). Our findings also suggest that
abluminal astrocytes and high shear stress are both neces-
sary to establish a tight vascular bed [4,6,10,37,38]. In fact,
when the capillary modules were established undervenular level of shear stress and vice versa, (venule mod-
ules established under capillary-like shear stress levels; see
Figure 3B) no TEER increase suggesting the formation of
stringent vascular bed was observed.
BBB opening following exposure to hyperosmotic man-
nitol is common clinical procedure used to enhance che-
motherapeutic drug penetration into the CNS to treat
patients with metastatic or primary brain tumors [46].
Hyperosmotic opening of the BBB is mediated by vaso-
dilatation and shrinkage of cerebrovascular endothelial
cells (and perhaps glia), with widening of the inter-
endothelial tight junctions to an estimated radius of 200
Ǻ. This provides paracellular pathways previously lacking
that can facilitate the passage of substances across the brain
capillary endothelium [21,27,28,47]. Our results (see Figure 4)
demonstrated that loss of vascular integrity of in the DIV
capillary-venules model mimics the expected physiological
vascular response to hyperosmotic agents (magnitude and
duration) of the corresponding vascular segments in vivo.
The tightness of brain capillary vascular beds is the most
dependent upon the tight junctions’ (TJ) ability to seal the
space between adjacent endothelial cells. The presence of
tight junctions between endothelial cells in our capillary
model was demonstrated by electron microscopy [38] and
confirmed by functional assays that measured for example
permeability to K ions [37] The mechanisms of osmotic
blood–brain barrier disruption is believed to depend on
endothelial cell shrinkage. This may be caused by the expos-
ure to a hyperosmolar environment, efflux of water from the
endothelial cell and subsequent cytoskeletal rearrangement.
The latter may cause stretching of TJ and widening the inter-
endothelial space. The temporary formation of paracellular
routes of entry across the BBB as demonstrated by the
monophasic TEER decrease.
The effect of mannitol was strikingly different in the ven-
ule compared to capillary modules. Recovery was delayed
and overall disruption achieved was less notable at the
venular level; the latter may be due to its more prominent
paracellular pathway. There is no clear-cut explanation for
the delayed recovery of venular TEER after osmotic chal-
lenge. However, we would like to underscore that when we
performed experiments in vivo (rat, pig; intracarotid injec-
tions of mannitol) we found that at 30’-1 hr. intervals
white matter venules retained blood–brain barrier disrup-
tion properties (measured by different tracer means) while
gray matter small vessels (capillaries) were, at this time
point, “intact”. The fact that we can reproduce this finding
in vitro suggests that the persistence of disruption in larger
vessels, and venules as seen in white matter, is due to in-
trinsic properties rather than vascular access issues, or par-
enchymal influences. It is also critical to address the issue
of molecular mechanisms of osmotic disruption and reco-
very of TEER. For example, are TJ protein involved in a
transcriptional vs. positional way? Are other mechanisms
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findings require additional studies, and that only a side-by-
side comparison of our in vitro/in vivo will elucidate this.
Finally, it is striking that a clinically relevant procedure
such as osmotic BBBD has never been mechanistically
explored to show what truly are the mechanisms under-
lying increased permeability after intrarterial mannitol.
Oxygen delivery to the CNS is another important func-
tion bestowed upon the brain vessels. Recent studies have
shown that PO2 values increase from the post-capillary
venules to the distal vessels of the cerebrovascular net-
work and by contrast, measurements of the radial gradi-
ents are consistent with an increase oxygen loss [48].
These data support the hypothesis that venules may in-
deed play a critical role in oxygen delivery. These findings
are consistent with our data related to the metabolic be-
havior of capillary and venule segments. In fact, the highly
oxygenated blood from the arterial circulation reaching
the brain microcapillaries allows the BBB endothelium to
make use of the highly efficient aerobic-driven metabolic
respiration to meet the cellular bioenergetic demand and
to use less glucose in the process thus maximizing that
delivered into the brain (see Figure 5A). On the other
hand, if oxygen delivery to the brain primarily occurs at
the venular level as suggested by recent studies [48,49]
than a non-oxidative (anaerobic) metabolic behavior (see
Figure 5B and 5C) would minimize vascular oxygen con-
sumption leaving more oxygen available for brain delivery.
Furthermore, recent studies have clearly shown that shear
stress plays a key role in the modulation of bioenergetic
metabolism of vascular endothelial cells favoring the
utilization of the more energy rewarding aerobic pathway.
This perhaps also suggests an additional link between
shear stress/flow and vascular functions of the different
cerebrovascular territories. However, additional and more
specific studies will be necessary to validate this hypoth-
esis and to understand the underlying mechanisms.
A limitation of our study concerns the lack of peri-
cytes to the abluminal mixture of cells. Pericytes have
been shown to control several aspects of BBB function
in vivo [13,50] including “barriergenesis” (via release of
angiopoietin-1 [51]) and protection against hypoxia-
induced BBB disruption [52]. Although our preliminary
experiments (data not shown) revealed no significant
effects of pericytes on BBB tightness, these findings
needs to be carefully reproduced under different com-
binatory approaches of cells (astrocytes/pericytes in dif-
ferent ratios). In addition, functional BBB modulatory
effects specific for the endothelium or abluminal astro-
cytes (e.g., cell polarization) are still poorly understood
and need to be further investigated. Another limitation
of our study is that we did not attempt to isolate the dif-
ferentiating effects of shear vs. abluminal cell type. Thus,
how astrocytes or vascular smooth muscle influenceendothelial cell differentiation under conditions of equal
shear stress need to be further investigated. In
particular.
Conclusion
In summary, we have successfully established an in vitro
dynamic capillary-venule modular system capable of re-
producing the physiology and the functional characteris-
tics of multiple segments of the brain vascular network.
This innovative model represents a refinement of the
DIV-BBB, which has fostered many advances in our
understanding of the mechanisms regulating BBB func-
tion under normal and disease conditions [53]. The DIV
capillary-venule system provides critical, yet unexploited,
features to investigate the cerebrovascular response to
pathophysiological stimuli. This may help the develop-
ment and validation of novel CNS therapeutic strategies
to reduce the burden of many neurological diseases
characterized by poor CNS drug penetration or inflam-
matory cell interaction with the vascular wall.
Methods
Cell Culture
Normal adult human brain microvascular endothelial
cells (HBMEC, cat# 1000), human adult astrocytes (HA,
cat# 1800) and human brain vascular smooth muscle
cells (HBVSMC, cat# 1100) were purchased from Scien-
Cell Research Laboratories (San Diego, CA 92121).
HBMEC were expanded in 75 cm2 flasks pre-coated with
fibronectin (3μg/cm2). Growth medium consisted of
MCDB 105 (Sigma, Cat# M6395), 10% human AB serum
(SIGMA, Cat# S-7148), 15 mg/100 ml of endothelial cell
growth supplement (ECGS, Cat.# 1052), 800 units/ml of
heparin (Sigma, cat# H3393), 100 units/ml penicillin G
sodium and 100 mcg/ml streptomycin sulfate. HA were
cultured in Poly-d-Lysine pre-coated flasks (3 μg/cm2)
with Dulbecco’s modified essential medium (DMEM-
F12) supplemented with 2mM glutamine, 5% fetal bo-
vine serum (FBS), 100 units of penicillin G sodium per
ml, and 100 μg of streptomycin sulfate per ml.
Smooth muscle cells medium (SMCM; cat# 1101) con-
sists of 500 ml of basal medium, 10 ml of fetal bovine
serum (FBS, Cat. No. 0010), 5 ml of smooth muscle cell
growth supplement (SMCGS, Cat. No. 1152) and 5 ml of
penicillin/streptomycin solution (P/S, Cat. No. 0503). Cell
cultures were maintained at 37°C in a humidified atmos-
phere with 5% CO2. Cellular growth was monitored every
day by inspection with phase contrast microscopy. To
minimize the dedifferentiation process cell cultures were
expanded for no more than two cycles.
DIV-Capillary-Venule setup
Brain primary EC and astrocytes were initially cultured in
the DIV-capillary modules, as previously described [54].
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low polypropylene fibers inside a sealed chamber (the ex-
traluminal space or ECS) accessible by ports. The system
allows to reproducing the hemodynamic characteristics
(shear stress and blood pressure) of the corresponding
vascular segment in vivo. Flow was channeled through the
bundle of artificial capillaries by gas permeable silicon tub-
ing that allows for the exchange of O2 and CO2. A pump
(CellMaxW QUAD Artificial Capillary Cell Culture System,
Spectrum Laboratories Inc. CA) feeding the system gener-
ates pulsatile high velocity flow and systolic blood pressure
(which may range from 80 to 300mmHg) within the sili-
con tubing, thereby mimicking a pattern of intravascular
perfusion comparable to that of physiological blood flow
in vivo [54]. The luminal surface of the hollow fiber was
pre-coated with 3 μg/cm2 of fibronectin to facilitate endo-
thelial cells adhesion. The abluminal surface was instead
pre-coated with 3 μg/cm2 of poly-D-lysine to allow for
astrocytes adhesion. The fibers used for capillary vs. ven-
ule modules were the same. TEER was measured by a set
of electrodes connected to the TEER readout apparatus
(Flocel, Inc.).
Endothelial cells were first inoculated into the luminal
compartment and allowed to adhere under static condi-
tions over a 24-hr period. In order to achieve higher levels
of cell attachment, the flow path was temporarily canalized
through the extra-capillary space. Astrocytes were seeded
on the abluminal surface of the fibers 24 hours after the
initial loading of the endothelial cells. Following astrocytes
seeding, the intraluminal flow was re-established and the
vascular endothelium was initially exposed to a low level
shear stress (1 dyne/cm2) for 24 hours.
The venules module consisted of 19 hollow fibers (in-
stead of 3). The higher number of artificial capillaries
allowed us to mimic the intramural pressure and vascular
shear stress found in the corresponding cerebrovascular
segment [42] once the module was serially connected
(downstream) to the capillary unit (see Figure 1A and B).
The venular hollow fibers were pre-coated (lumen and
ablumen) with fibronectin (3μg/cm2) to facilitate the ad-
hesion of endothelial cell (in the lumen) and that of
HVSM (ablumen). The DIV-venules was then separately
exposed to an initial intraluminal shear stress of 1 dyne/
cm2 for 24 hours prior attachment to the capillary mod-
ule. Flow was then gradually adjusted to reach the physio-
logical levels of shear stress and intramural pressure
in vivo.
TEER measurement
Capillary and venules vascular integrity was monitored in
real time by a computer-controlled TEER measurement
system (Flocel Inc., Cleveland, OH 44103). This device
utilizes electronic multiplexing to reliably measure the
TEER in multiple cartridges/modules in quick succession[54,55]. The device interfaced directly to a PC computer
via Universal Serial Bus (USB). As previously described,
(see also vendor site) the system applies an excitation volt-
age (0.06 V) across the excitation electrodes inserted in
each cartridge in the luminal and extraluminal compart-
ments. A microcontroller computes the resistivity and
capacitance per cm2 of the vascular bed from physical
parameters. The values of capacitance are automatically
calculated by comparison of the voltage and current wave-
forms. TEER was measured continuously from the initial
setup throughout the course of each experiment. Previous
work in our laboratory [40,55,56] showed a direct (inverse)
relationship between TEER and vascular permeability.Drug Permeability in capillary and venules modules:
uptake of [14C]-phenytoin, [14C]-diazepam and
[3H]-sucrose
Boluses (0.5 ml each) of the radioactive tracers [3H]-
sucrose (Amersham, Piscataway – NJ, Cat# TRA-332),
[14C]-phenytoin (PerkinElmer, Boston – MA, Cat# NEC-
246), and [14C]-diazepam (Amersham, Piscataway – NJ,
Cat# CFA-591) were injected upstream (before the flow
enters the capillary module) into the lumen as described
previously [25]. The diffusion of the compounds through
the vascular bed into the extracapillary space of each seg-
ment of the DIV capillary-venules system was monitored
over time while maintaining 1 mL/min intraluminal perfu-
sion rate. A total of 1 μCi per compound was used. Sam-
ples were simultaneously taken from the lumen and the
ECS (100 μL each) of each module as previously described
[25], at time zero (immediately after the injection) and at
1, 5, 10, 15, and 20 min post injection. The luminal sam-
ples were collected downstream of each module (where the
media leave the cartridge to enter the silicon tubing). Sam-
ples were then introduced into vials with 4 mL of Ready
Protein Beckman scintillation cocktail (Packard Ultima
Gold, ECN, Costa Mesa, CA, USA). Radioactivity was
counted with an LS 6500 scintillation counter (Beckman).
Permeability across the vascular bed of each module was
calculated by graphical integration of drug concentration in
the corresponding lumen and ECS over 20 min. Permeabil-
ity for a given compound in “single pass” experiments was
calculated as described elsewhere [25]. In brief, the perme-
ability values were obtained by integrating the area under
the ECS and lumen data points (AUC) according to the
final equation described below.
In this equation (derived from Fick’s Law) CECS (t) and
CECS (0) are the extraluminal space concentrations of the
compound x, at time zero (0) and time (t) = 20 minutes.
This time interval was chosen to minimize the contribution
of drug reperfusion. VECS is the volume of the abluminal
space (1.33 and 1.15 cm3 in the capillary and venule mod-
ules respectively); A is the capillary surface area (= 2.1 and
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To obtain the P value in cm/sec we have divided by 60.
Note that the integral of luminal and ECS values vary
only as function of time since the driving force for drug
transfer is not (in this equation) concentration dependent.
Furthermore, the diffusion of the drug is independent
from the dimension of the units of measurement and the
same permeability values (in cm/sec) is obtained whether
using molar concentration (M) or counts per minute
(cpm) units. The permeability results for each compound
were then compared to the octanol-water partition coeffi-
cient (XLogP) [57] reported for the specific substance
(PubChem) to establish a comparative relation between
permeability and lipophilicity.
Pressure analysis
Intramural pressure and waveform geometry of flow pas-
sing through each module (capillary and post-capillary)
were assessed by four-channel BioTRans2 pressure ampli-
fier (Flocel Inc., Cleveland, OH 44103) connected to 4
independent BioTrans2 pressure transducers. Each trans-
ducer was attached to the corresponding inlet and outlet
intraluminal sampling ports (ILS port) of each module (see
Figure 1A). After a fixed period of 2 minutes (necessary to
stabilize the pressure fluctuation), the pulsatile flow pat-
terns were measured and recorded for 60 seconds. The sys-
tem was connected to an Axon Digitizer (Digidata1322A;
Molecular Devices, Inc. Sunnyvale, CA 94089) that func-
tioned as an active interface between the four-channel Bio-
TRans2 pressure amplifier and the computer used for data
acquisition.
Glucose and lactate measurement
Glucose consumption and lactate production were deter-
mined via a dual-channel immobilized oxidase enzyme
analyzer (YSI 2700 SELECT; YSI Inc., Yellow Springs, OH)
in medium samples collected from the capillary and venule
modules. Daily assessment of the oxidase enzyme mem-
brane integrity was made according to manufacturer
recommendations. The sampling protocol was set to recali-
brate the machine every six samples as multiple samples
were analyzed in the same run. Samples were kept frozen
after being collected and processed later simultaneously.
BBB “opening” by hyperosmolar mannitol
Infusion of 2 ml of growth medium containing mannitol
(1.6M) was used to osmotically open the endothelial layer
forming the vascular bed of the capillary and post-capillary
segments respectively [28]. The mannitol solution was pre-
pared under sterile conditions and injected intraluminally
at a perfusion rate of 1 ml/min (total perfusion time was
120 sec). TEER was monitored in real time in both capil-
lary and venule modules for the duration of the experi-
ment to assess for loss of vascular integrity (opening) andrecovery. Osmotic opening via hyperosmolar mannitol in-
jections is a clinical procedure used to facilitate the passage
of chemotherapic drugs across the BBB into the CNS for
the treatment of malignant brain tumors [58].
Statistical analysis
For parametric variables (e.g., TEER levels, glucose con-
sumption, lactate production), differences between popu-
lations were analyzed by ANOVA. P values <0.05 were
considered statistically significant. Repeated measure
ANOVA was performed by JPM software of time-lapse
experiments. No differences in significance were found
compared to one way ANOVA. Bonferroni analysis was
used to account for comparisons of multiple parameters
among groups. Based upon previous experience each ex-
periment was repeated in triplicate. This was sufficient to
demonstrate statistical significance for positive findings.
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